Fort Baker Capital Management LP, Steven Patrick Pigott, and Fort Baker Capital, LLC filed an amended Schedule 13G with the SEC on November 16, 2026, disclosing a combined beneficial ownership position in Oaktree Acquisition Corp. III Life Sciences, a special purpose acquisition company whose Class A ordinary shares are listed on NASDAQ:OACC.

Key Highlights

  • Three reporting persons: Fort Baker Capital Management LP (investment adviser), Fort Baker Capital, LLC (general partner), and Steven Patrick Pigott (Chief Investment Officer) each report the same position jointly but disclaim group membership.
  • Shares held: Each reporting person lists 1,541,966 Class A ordinary shares of Oaktree Acquisition Corp. III Life Sciences beneficially owned.
  • Ownership percentage: The 1,541,966 shares represent 7.8% of the class, calculated against 19,783,010 Class A ordinary shares outstanding as of August 12, 2026, per the issuer's quarterly report filed that date.
  • Voting and dispositive power: All 1,541,966 shares are held on a shared basis; sole voting power and sole dispositive power are each reported as zero for all three reporting persons.
  • Triggering event date: The event requiring this filing occurred on September 30, 2026, according to the statement.
  • Direct holder: According to the filing, Fort Baker Capital Management LP directly holds the 1,541,966 Class A ordinary shares.

Fort Baker Capital Discloses Amended Beneficial Ownership in a Life Sciences SPAC

According to the amended Schedule 13G filed on November 16, 2026, Fort Baker Capital Management LP, a Delaware limited partnership operating as a registered investment adviser, directly holds 1,541,966 Class A ordinary shares, par value $0.0001 per share, in Oaktree Acquisition Corp. III Life Sciences. The issuer is a special purpose acquisition company focused on the life sciences sector, with its principal executive offices located at 333 South Grand Avenue, 28th Floor, Los Angeles, California 90071. The CUSIP number for the reported class of securities is G6717R104.

The filing identifies Steven Patrick Pigott as a United States citizen serving as Limited Partner and Chief Investment Officer of Fort Baker Capital Management LP. Fort Baker Capital, LLC, a Delaware limited liability company, is disclosed as the general partner of Fort Baker Capital Management LP. All three reporting persons share the same principal business address at 700 Larkspur Landing Circle, Suite 275, Larkspur, CA 94939. The filing states that the reporting persons are acting jointly but expressly disclaim membership in a group, and each also disclaims beneficial ownership of the reported securities except to the extent of that person's pecuniary interest.

The filing further states that the 7.8% ownership percentage was derived from the total of 19,783,010 Class A ordinary shares reported as outstanding in the issuer's quarterly report filed with the SEC on August 12, 2026. The certification included in the statement affirms, in the words of the filing, that the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer."

What Was Disclosed

This amended Schedule 13G discloses that Fort Baker Capital Management LP, Fort Baker Capital, LLC, and Steven Patrick Pigott collectively report shared beneficial ownership of 1,541,966 Class A ordinary shares of Oaktree Acquisition Corp. III Life Sciences, representing 7.8% of the class, as of September 30, 2026.